Results 151 to 160 of about 212,304 (319)
Price regulation and generic competition in the pharmaceutical market [PDF]
In March 2003 the Norwegian government implemented yardstick based price regulation schemes on a selection of drugs experiencing generic competition. The retail price cap, termed “index price”, on a drug (chemical substance) was set equal to the average ...
Dalen, Dag Morten +2 more
core
Insurance of the Costs of Pharmaceuticals in the Netherlands: A Law and Economics Perspective
, 2002 Niels Philipsen, Michaël Faure
openalex +2 more sources
Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study
Risk Management and Healthcare Policy, 2019 Farbod Ebadi Fardazar,1 Ali Sarabi Asiabar,2 Hossein Safari,1 Mojgan Asgari,3 Ali Saber,4 Amir Ali Ebadi Fard Azar5 1School of Public Health, Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran; 2School of Health ...
Ebadi Fardazar F +5 more
doaj
Indicators to identify cancer screening providers with suboptimal case detection: A scoping review
International Journal of Cancer, EarlyView.What's New? Quality control of cancer screening programs is essential to maintaining high public health standards. Here, the authors reviewed monitoring of case detection in cervical and colorectal cancer screening programs in Europe, and evaluated its effectiveness. They analysed 20 different measures used for this purpose and showed that many of them
Jiayao Lei +5 more
wiley +1 more source
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal [PDF]
The poorest nations of the world suffer from extreme disease burdens, which go largely untreated because weak incomes and the prevailing system of intellectual property rights fail to provide sufficient incentives to develop new treatments and distribute
Ganslandt, Mattias +2 more
core
International Journal of Cancer, EarlyView.What's New? This study shows that absolute and relative educational inequalities in cervical cancer mortality are much larger in the Baltic countries than in Finland, where an organized screening programme was introduced more than 40 years earlier. After the introduction of organized screening, cervical cancer mortality declined among low‐educated ...
Oskar Nõmm +7 more
wiley +1 more source
Pharmacoeconomic Analysis in Saudi Arabia: An Overdue Agenda Item for Action
Annals of Saudi Medicine, 2011 Pharmacoeconomics is a branch of health economics related to the most economical and efficient use of pharmaceuticals. Pharmacoeconomic research identifies, measures and compares the costs and outcomes (clinical, economic and humanistic) of ...
Al-Jazairi Abdulrazaq +2 more
doaj
Pharmaceutical Patents: Incentives for R&D or Marketing? [PDF]
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry ...
Kurt R. Brekke, Odd Rune Straume
core
Law and Economics of Patent Settlements in the Pharmaceutical Industry
, 2020 Jonas Severin Frank
openalex +1 more source